Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
- 1 April 2004
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (7), 822-825
- https://doi.org/10.1016/j.amjcard.2003.12.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of Reteplase and Alteplase on Platelet Aggregation and Major Receptor Expression During the First 24 Hours of Acute Myocardial Infarction TreatmentJournal of the American College of Cardiology, 1998
- Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1995
- Plasmin-Mediated Activation of Contact System in Response to Pharmacological ThrombolysisCirculation, 1995
- Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII).Proceedings of the National Academy of Sciences, 1992
- Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1992
- Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.Circulation, 1992
- Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.Circulation, 1992
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityBlood, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.Journal of Clinical Investigation, 1983